122 related articles for article (PubMed ID: 3511085)
21. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
22. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
23. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
Hussain R; Dockrell HM; Chiang TJ
Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
[TBL] [Abstract][Full Text] [Related]
24. The limited spectrum of antinuclear antibodies in leprosy.
Miller RA; Wener MH; Harnisch JP; Gilliland BC
J Rheumatol; 1987 Feb; 14(1):108-10. PubMed ID: 3553585
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7.
Harboe M; Closs O; Reitan LJ; Draper P
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):147-58. PubMed ID: 6168595
[TBL] [Abstract][Full Text] [Related]
26. Lupoid sclerosis with antiphospholipid and antimyelin antibodies.
Marullo S; Clauvel JP; Intrator L; Danon F; Brouet JC; Oksenhendler E
J Rheumatol; 1993 Apr; 20(4):747-9. PubMed ID: 8496878
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of modified lepro-agglutination as screening test for leprosy.
Thawani G; Mukherjee A; Bhatia VN
Indian J Lepr; 1994; 66(3):315-20. PubMed ID: 7861046
[TBL] [Abstract][Full Text] [Related]
28. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
[TBL] [Abstract][Full Text] [Related]
29. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
[TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
Sharma VK; Saha K; Sehgal VN
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
33. [Immunofluorescence and detection of serum antibodies in leprosy].
Cottenot F; Merklen FP
Dermatol Int; 1968; 7(2):113-5. PubMed ID: 4911457
[No Abstract] [Full Text] [Related]
34. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
35. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18.
Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM
Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
37. Use of protein antigens for early serological diagnosis of leprosy.
Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
[TBL] [Abstract][Full Text] [Related]
38. Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy.
Ellie E; Younes-Chennoufi AB; Couto A; Vital A; Hilmi S; Demotes-Mainard J; Baumann N; Petry KG
J Peripher Nerv Syst; 1997; 2(1):43-8. PubMed ID: 10975735
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of diversified antigens for detection of Mycobacterium leprae antibodies from leprosy patients and contacts.
Singh NB; Bhatnagar S; Choudhary A; Gupta HP; Kaul SM
Indian J Exp Biol; 1994 Jul; 32(7):478-81. PubMed ID: 7959924
[TBL] [Abstract][Full Text] [Related]
40. Comparison between autoantibodies in malaria and leprosy with lupus.
Bonfa E; Llovet R; Scheinberg M; de Souza JM; Elkon KB
Clin Exp Immunol; 1987 Dec; 70(3):529-37. PubMed ID: 3325202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
